TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway

Ting-Ting Zhao(Shenyang Fifth People Hospital), Zhi‐Feng Miao(Kaohsiung Medical University), Yingying Xu(Wannan Medical College), Huiting Dong(Zhengzhou University), Peng Xing(First Hospital of China Medical University), Qun Liu(Brookhaven National Laboratory), Feng Jin(Hebei University), Jiguang Li(Shenyang Fifth People Hospital), Hao Xu(Lianyungang Maternal and Children’s Hospital), Guolian Zhu(Shenyang Fifth People Hospital), Songcheng Yin(Sun Yat-sen University)
Journal of Cancer
January 1, 2018
Cited by 54


Related Papers